{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:49:45Z","timestamp":1777880985267,"version":"3.51.4"},"reference-count":52,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["SAGE Open Medicine"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Biological agents have revolutionized care in specialties such as oncology, immunology, infectious diseases, and genetic disorders, offering targeted actions on specific molecules or select immune cells. Monoclonal antibodies, known for their high specificity and precision, represent one of the most significant and rapidly expanding categories of these agents. Understanding the drug utilization patterns of monoclonal antibodies is crucial to ensure their optimal use, especially given their high cost and potential adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This analytical cross-sectional study was conducted in a secondary hospital in the United Arab Emirates. Patients of either gender receiving monoclonal antibodies at the study site were included. Treatment patterns, utilization, and factors associated with the discontinuation of monoclonal antibodies were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Hyperlipidemia (136, 39.1%) was the most common indication for monoclonal antibodies, followed by prophylaxis of respiratory syncytial virus infection in congenital heart disease (104, 29.9%) and osteoporosis (42, 12.1%). Evolocumab was the most commonly prescribed monoclonal antibody (135, 38.8%), followed by palivizumab (104, 29.9%), and dupilumab (38, 10.9%). The majority of monoclonal antibodies demonstrated a prescribed daily dose to defined daily dose ratio of 1.0, reflecting their appropriate utilization. One hundred twenty-nine patients (37.0%) discontinued their treatment during the study. Patient\u2019s level of education (OR: 0.416, 95% CI: 0.183\u20130.943, p\u2009=\u20090.036), BMI (OR: 2.358, 95% CI: 1.164\u20134.777, p\u2009=\u20090.017), number of concomitant medications (OR: 2.457, 95% CI: 1.202\u20135.025, p\u2009=\u20090.014), and treatment duration (OR: 9.180, 95% CI: 4.909\u201317.165, p\u2009&lt;\u20090.001) were identified as predictors of discontinuation of monoclonal antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study represents the first comprehensive investigation in the United Arab Emirates focused on treatment patterns, utilization, and discontinuation of monoclonal antibodies among the local population. Monoclonal antibodies were prescribed for the management of a wide range of clinical conditions. The study reports appropriate utilization of most monoclonal antibodies and identifies factors such as patient education level, BMI, concomitant medications, and treatment duration as independent predictors of monoclonal antibody treatment discontinuation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20503121241271817","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T06:57:12Z","timestamp":1724050632000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment patterns and factors associated with discontinuation of monoclonal antibodies"],"prefix":"10.1177","volume":"12","author":[{"given":"Muzoon Matar Saleh","family":"Alkaabi","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-8158","authenticated-orcid":false,"given":"Syed Arman","family":"Rabbani","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padma GM","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai Ismail","family":"Mohamedelhassan","sequence":"additional","affiliation":[{"name":"Dibba Hospital, Al Fujairah, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"bibr1-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2018.09.002"},{"key":"bibr2-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00516-z"},{"key":"bibr3-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2017.1343709"},{"key":"bibr4-20503121241271817","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-3-220"},{"key":"bibr5-20503121241271817","unstructured":"Malik B, Ghatol A. Understanding how monoclonal antibodies work, http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31820172 (2023, accessed 11 November 2023)."},{"key":"bibr6-20503121241271817","doi-asserted-by":"publisher","DOI":"10.2174\/0126673878260516231017165459"},{"key":"bibr7-20503121241271817","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051434"},{"key":"bibr8-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-022-00100-4"},{"key":"bibr9-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103415"},{"key":"bibr10-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00203-w"},{"key":"bibr11-20503121241271817","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1084614"},{"key":"bibr12-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2023.04.010"},{"key":"bibr13-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2021.05.016"},{"key":"bibr14-20503121241271817","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11072086"},{"key":"bibr15-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2022.2073213"},{"key":"bibr16-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2023.100787"},{"key":"bibr17-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.21872"},{"key":"bibr18-20503121241271817","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2020.19053"},{"key":"bibr19-20503121241271817","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v103.6505"},{"key":"bibr20-20503121241271817","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S328653"},{"key":"bibr21-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2020.11.004"},{"key":"bibr22-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.0023"},{"key":"bibr23-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.06.011"},{"key":"bibr24-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.11.002"},{"key":"bibr25-20503121241271817","unstructured":"World Health Organization. World Health Organization collaborating centre for drug statistics methodology\u2014purpose of the ATC\/DDD system, https:\/\/www.whocc.no\/atc_ddd_methodology\/purpose_of_the_atc_ddd_system\/ (2023, accessed 11 November 2023)."},{"key":"bibr26-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2022.03.003"},{"key":"bibr27-20503121241271817","unstructured":"American Academy of Pediatrics. Updated guidance: use of palivizumab prophylaxis to prevent hospitalization from severe respiratory syncytial virus infection during the 2022-2023 RSV season, https:\/\/www.aap.org\/en\/pages\/2019-novel-coronavirus-covid-19-infections\/clinical-guidance\/interim-guidance-for-use-of-palivizumab-prophylaxis-to-prevent-hospitalization\/ (2023, accessed 10 November 2023)."},{"issue":"9","key":"bibr28-20503121241271817","volume":"15","author":"Salim S","year":"2023","journal-title":"Cureus"},{"key":"bibr29-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.08.102"},{"key":"bibr30-20503121241271817","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13172721"},{"key":"bibr31-20503121241271817","unstructured":"Global Initiative for Asthma. 2023 GINA main report\u2014Global Initiative for Asthma\u2014GINA, 2023. accessed 11 November 2023."},{"key":"bibr32-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"bibr33-20503121241271817","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.401"},{"key":"bibr34-20503121241271817","unstructured":"American Academy of Otolaryngology-Head and Neck Surgery. Clinical Practice Guideline: Adult Sinusitis (Update)\u2014American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), https:\/\/www.entnet.org\/quality-practice\/quality-products\/clinical-practice-guidelines\/adult-sinusitis\/ (2023, accessed 11 November 2023)."},{"key":"bibr35-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19631"},{"key":"bibr36-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2022.107058"},{"key":"bibr37-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05951-1"},{"key":"bibr38-20503121241271817","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1188969"},{"key":"bibr39-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2023.06.011"},{"key":"bibr40-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2010.00764.x"},{"key":"bibr41-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1314-1"},{"key":"bibr42-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.01.048"},{"key":"bibr43-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01636-8"},{"key":"bibr44-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009280"},{"key":"bibr45-20503121241271817","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1074044"},{"key":"bibr46-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2021.1971700"},{"key":"bibr47-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz001"},{"key":"bibr48-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14552"},{"key":"bibr49-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17944"},{"key":"bibr50-20503121241271817","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S1458"},{"key":"bibr51-20503121241271817","first-page":"2020","volume":"360","author":"Kumar A","journal-title":"Crohn\u2019s Colitis"},{"key":"bibr52-20503121241271817","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.139774"}],"container-title":["SAGE Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20503121241271817","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20503121241271817","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20503121241271817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:28:51Z","timestamp":1777595331000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20503121241271817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":52,"alternative-id":["10.1177\/20503121241271817"],"URL":"https:\/\/doi.org\/10.1177\/20503121241271817","relation":{},"ISSN":["2050-3121","2050-3121"],"issn-type":[{"value":"2050-3121","type":"print"},{"value":"2050-3121","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"article-number":"20503121241271817"}}